MasurH. Therapy for AIDS. In: MandellGLDouglasRGBennettJE, eds. Principles and practice of infectious diseases. 3rd ed.New York: Churchill Livingstone, 1990: 1102–11.
2.
CoopmanSAJohnsonRAPlattRSternRS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med1993; 328: 1670–4.
3.
GordinFMSimonGLWofsyCBMillsJ. Adverse reactions to trimethoprim-sulfamethoxazole in patients with acquired immunodeficiency syndrome. Ann Intern Med1984; 100: 495–9.
4.
JaffeHSAbramsDIAmmannAJLewisBJGoldenJA. Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men. Lancet1983; 2: 1109–11.
5.
MoeAAHardyWD. Pneumocystis carinii infection in the HIV-seropositive patient. Infect Dis Clin North Am1994; 8: 331–64.
6.
KreuzWGungorTLotzCFunkMKornhuberB. “Treating through” hypersensitivity to co-trimoxazole in children with HIV infection (letter). Lancet1990; 336: 508–9.
7.
HughesTEAlmgrenJDMcGuffinRWOmotoRJ. Co-trimoxazole desensitization in bone marrow transplantation (letter). Ann Intern Med1986; 105: 148.
8.
FinegoldI. Oral desensitization to trimethoprim-sulfamethoxazole in a patient with acquired immunodeficiency syndrome. J Allergy Clin Immunol1986; 78: 905–8.
9.
WhiteMVHaddadZHBrunnerESainzC. Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia. Ann Allergy1989; 62: 177–9.
10.
AbsarNDaneshavarHBeallG. Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients. J Allergy Clin Immunol1994; 93: 1001–5.